Prednisone acetate
- Generic Name
- Prednisone acetate
- Drug Type
- Small Molecule
- Chemical Formula
- C23H28O6
- CAS Number
- 125-10-0
- Unique Ingredient Identifier
- OU93QEL83U
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Phase 3
Recruiting
- Conditions
- Prostatic NeoplasmsMetastatic Castration-resistant Prostate Cancer (mCRPC)
- Interventions
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 1500
- Registration Number
- NCT06136650
- Locations
- 🇺🇸
The University of Arizona Cancer Center - North Campus ( Site 0073), Tucson, Arizona, United States
🇺🇸UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles, California, United States
🇺🇸University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange, California, United States
Dextenza With ILUX for Treatment of MGD
Phase 4
Completed
- Conditions
- Evaporative Dry EyeMeibomian Gland Dysfunction
- Interventions
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Warrenville Eyecare
- Target Recruit Count
- 30
- Registration Number
- NCT04658927
- Locations
- 🇺🇸
Warrenville EyeCare & LASIK, Warrenville, Illinois, United States
COrticosteroids in acUte uRticAria in emerGency dEpartment
Phase 3
Active, not recruiting
- Conditions
- UrticariaAngiœdema
- Interventions
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 240
- Registration Number
- NCT03545464
- Locations
- 🇫🇷
Hospital Louis MOURIER, Colombes, Ile de France, France
A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma
- First Posted Date
- 2008-05-29
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Amgen
- Target Recruit Count
- 12
- Registration Number
- NCT00686335
- Locations
- 🇫🇷
Hôpital Bichat, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath